although
rhinoviru
rv
respiratori
infect
trigger
asthma
exacerb
etiolog
associ
viru
sever
exacerb
well
clinic
characterist
adult
risk
rvassoci
asthma
necessit
hospit
establish
method
conduct
cohort
studi
adult
prospect
enrol
hospit
admiss
asthma
exacerb
patient
characterist
frequenc
rv
nasal
specimen
analyz
reversetranscript
polymeras
chain
reaction
rtpcr
asthmarel
hospit
admiss
convalesc
followup
visit
result
rv
detect
rtpcr
hospit
patient
period
patient
return
followup
visit
rv
detect
strongli
associ
hospit
asthma
adjust
odd
ratio
confid
interv
ci
adjust
baselin
asthma
sever
rvposit
patient
like
rvneg
patient
current
smoker
nonus
inhal
corticosteroid
icss
adjust
ci
p
p
conclus
rv
respiratori
infect
etiolog
agent
sever
asthma
exacerb
necessit
hospit
adult
compar
hospit
patient
asthma
rv
neg
rvposit
patient
significantli
like
smoker
nonus
icss
infect
common
respiratori
virus
frequent
trigger
exacerb
asthma
earli
studi
investig
relationship
employ
viral
cultur
techniqu
found
frequenc
virusasmedicin
follow
conduct
research
data
collect
studi
nurs
collect
inform
clinic
symptom
medic
histori
pediatr
household
contact
detail
smoke
environment
tobacco
exposur
obtain
spirometri
vital
sign
nasal
lavag
specimen
serum
ige
determin
complet
physic
assess
patient
follow
daili
hospit
chronic
asthma
diseas
sever
measur
use
john
hopkin
asthma
sever
scale
lower
valu
indic
milder
diseas
patient
seen
outpati
gener
clinic
research
center
month
acut
asthma
exacerb
underw
similar
comprehens
evalu
skinprick
test
common
aeroallergen
sociat
asthma
exacerb
newer
molecular
techniqu
demonstr
virus
associ
asthma
exacerb
children
adult
rhinoviru
rv
picornaviru
respiratori
viru
frequent
associ
asthma
exacerb
howev
studi
implic
viru
primarili
assess
viral
detect
singl
time
point
perform
nonhospit
patient
asthma
fewer
investig
examin
relationship
rv
asthma
exacerb
sever
enough
requir
hospit
johnston
et
al
demonstr
correl
exist
season
pattern
upper
respiratori
tract
infect
hospit
admiss
asthma
children
adult
howev
prospect
design
studi
directli
examin
role
rv
sever
asthma
exacerb
perform
confirm
result
addit
studi
date
examin
clinic
characterist
adult
admit
hospit
rvassoci
asthma
exacerb
purpos
present
studi
evalu
associ
rv
infect
asthma
exacerb
precipit
hospit
admiss
mean
reversetranscript
rt
polymeras
chain
reaction
pcr
detect
differ
time
pointshospit
admiss
convalesc
followup
visitand
character
clinic
featur
atrisk
patient
five
day
per
week
full
period
patient
year
age
older
hospit
vanderbilt
univers
medic
center
vumc
nashvil
tn
diagnosi
acut
asthma
approach
studi
inclus
review
hospit
chart
prior
medic
record
consult
current
treat
hospit
physician
use
confirm
diagnosi
asthma
exclud
diagnos
chronic
pulmonari
diseas
patient
exclud
concurr
congest
heart
failur
anoth
chronic
pulmonari
diseas
could
account
acut
ill
previous
enrol
criteria
diagnosi
acut
asthma
includ
confirm
asthma
diagnosi
review
prior
record
current
admiss
consist
asthma
diseas
exacerb
includ
current
treat
physician
clinic
diagnosi
asthma
presenc
dyspnea
wheez
respiratori
distress
attribut
anoth
cardiopulmonari
process
elig
adult
approach
surveil
day
rv
infect
determin
cell
mucu
concentr
bottom
eppendorf
tube
nasal
lavag
sampl
centrifug
min
supernat
remov
except
final
ml
rna
extract
cell
mucu
pellet
trizol
reagent
gibcobrl
sigma
describ
elsewher
rna
revers
transcrib
use
superscript
ii
revers
transcriptas
invitrogen
presenc
random
primer
promega
describ
elsewher
first
pcr
touchdown
reaction
cycl
use
primer
upstream
downstream
amplifi
region
untransl
region
picornavirus
includ
rv
second
pcr
perform
describ
elsewher
primer
downstream
primer
first
pcr
rv
nest
amplifi
region
specif
rv
group
size
pcr
product
verifi
agaros
electrophoresi
result
quantit
instead
indic
presenc
absenc
rv
control
pcr
run
includ
sampl
contain
reagent
cdna
sampl
contain
cdna
prepar
human
rv
type
rna
detect
sensit
nest
pcr
assay
rv
particlessampl
infecti
unit
rv
contain
viru
particl
sensit
assess
cdna
sampl
prepar
known
amount
viru
particl
standard
extract
cdna
synthesi
procedur
briefli
sucros
densiti
gradientpurifi
viru
particl
gener
quantifi
optic
assumpt
mg
virion
per
od
unit
describ
elsewher
viru
particl
serial
dilut
pb
rna
extract
cdna
synthes
dilut
nest
pcr
assay
describ
result
show
sampl
contain
viru
particl
per
extract
yield
visibl
pcr
product
agaros
gel
tobacco
exposur
secondhand
smoke
exposur
current
smoke
defin
quantifi
person
report
andor
elev
urinari
cotinin
level
determin
ga
chromatographi
nation
medic
servic
willow
grove
pa
patient
urin
cotinin
level
ngml
categor
current
smoker
level
ngml
categor
expos
environment
tobacco
smoke
regardless
selfreport
smoke
statu
outcom
major
outcom
interest
number
patient
human
rv
infect
time
point
characterist
patient
rvassoci
asthma
exacerb
statist
analysi
point
preval
rv
infect
hospit
asthma
convalesc
visit
calcul
baselin
characterist
compar
use
x
test
fisher
exact
test
categor
variabl
wilcoxon
ranksum
test
compar
continu
variabl
adjust
odd
ratio
or
obtain
use
gener
estim
equat
model
determin
independ
associ
rv
infect
hospit
followup
visit
control
baselin
characterist
achiev
adequ
regress
coeffici
power
first
princip
compon
use
account
variat
age
current
smoke
statu
sex
covari
or
confid
interv
ci
smoke
use
inhal
corticosteroid
icss
obtain
logist
regress
model
adjust
asthma
sever
collinear
check
found
among
smoke
use
ic
model
addit
adjust
first
princip
compon
age
sex
asthma
sever
score
result
differ
significantli
model
adjust
asthma
sever
data
shown
test
interact
smoke
use
icss
perform
calcul
loglikelihood
differ
model
without
crossproduct
term
test
perform
signific
level
use
infer
sa
version
sa
institut
use
report
p
valu
unadjust
multipl
test
among
individu
adult
patient
hospit
acut
asthma
exacerb
femal
mean
age
year
white
black
attain
greater
high
school
educ
patient
receiv
medic
care
primari
care
physician
alon
patient
user
icss
current
smoker
detect
rv
nasal
wash
sampl
found
posit
rv
rtpcr
hospit
admiss
patient
seventysix
patient
return
convalesc
followup
visit
return
visit
patient
found
rv
posit
rtpcr
patient
nasal
congest
rhinorrhea
chest
tight
wheez
forc
expiratori
volum
fev
predict
time
followup
twelv
patient
posit
rv
admiss
return
followup
visit
none
test
posit
rv
rv
detect
strongli
associ
hospit
asthma
adjust
ci
patient
return
followup
visit
differ
nonreturn
patient
respect
age
sex
race
daili
bagonist
use
length
hospit
stay
howev
return
like
smoke
less
like
colleg
educ
less
like
use
icss
demograph
characterist
rvposit
patient
compar
rvneg
patient
rvposit
patient
hospit
asthma
like
younger
patient
patient
without
rv
infect
differ
note
race
highest
degre
educ
attain
mean
number
daili
bagonist
actuat
symptom
upper
respiratori
tract
infect
fev
time
admiss
differ
rvposit
rvneg
patient
followup
visit
fev
significantli
higher
among
patient
test
posit
rv
infect
vs
predict
spectiv
thu
time
hospit
p
p
followup
visit
chang
fev
greater
rvposit
patient
rvneg
patient
vs
p
p
rvposit
patient
rel
high
total
serum
ige
level
admiss
level
significantli
differ
rvneg
patient
followup
visit
avail
rvposit
patient
posit
reaction
least
inhal
allergen
skinprick
test
thirtyeight
patient
miss
skin
test
data
statist
signific
differ
group
note
signific
differ
group
regard
type
physician
treat
asthma
length
asthmarel
hospit
stay
chang
fev
first
h
hospit
asthma
entir
length
stay
discharg
fev
number
day
intens
care
unit
icu
icu
stay
data
shown
signific
differ
whether
patient
without
rv
infect
live
children
year
age
live
children
elderli
individu
attend
day
care
live
children
attend
school
exposur
children
work
environ
combin
variabl
incorpor
exposur
data
shown
univari
analys
rvposit
patient
like
smoke
nonus
icss
combin
factor
strongli
associ
rv
posit
ci
tabl
p
p
season
admiss
season
rv
admiss
determin
studi
period
depict
month
combin
year
circul
rv
throughout
year
seen
peak
spring
april
may
fall
septemberdecemb
rv
account
greatest
proport
hospit
asthma
septemb
greatest
absolut
number
admiss
may
figur
shown
etiolog
associ
rv
infect
adult
asthma
exacerb
necessit
hospit
care
identifi
clinic
characterist
patient
rv
infect
cohort
femal
sex
younger
age
current
smoke
ic
nonus
character
patient
hospit
rvassoci
asthma
previou
clinic
studi
suggest
rv
play
role
asthma
exacerb
investig
assess
rv
infect
singl
time
point
interpret
complic
high
preval
rv
posit
asymptomat
control
subject
first
studi
knowledg
assess
etiolog
role
rv
sever
asthma
exacerb
necessit
hospit
admiss
assess
viral
detect
use
rtpcr
hospit
followup
visit
studi
subject
rv
infect
associ
adult
asthma
admiss
studi
period
strongli
associ
hospit
asthma
ci
investig
shown
associ
rv
infect
asthma
exacerb
sever
popul
elsahli
et
al
found
patient
year
age
admit
acut
respiratori
ill
associ
common
cold
viruseith
rv
coronavirushad
asthma
two
investig
adult
attend
emerg
room
asthma
exacerb
detect
virus
sputum
patient
one
studi
report
rv
account
virus
identifi
two
prior
investig
hospit
rvassoci
sever
asthma
adult
found
rv
infect
preval
respect
first
studi
use
viral
cultur
techniqu
less
sensit
pcr
second
studi
studi
subject
regular
smoker
design
perform
statist
comparison
rv
detect
separ
time
point
two
addit
investig
associ
viral
upper
respiratori
tract
infect
sever
asthma
exacerb
adult
report
picornaviru
infect
preval
provid
specif
data
regard
rv
peak
preval
rvassoci
hospit
adult
popul
note
septemb
similar
septemb
peak
describ
children
clinic
characterist
patient
hospit
rvassoci
asthma
previous
describ
present
studi
rvposit
patient
rel
mild
baselin
asthma
evidenc
normal
followupconvalesc
fev
greater
revers
lung
function
significantli
lower
frequenc
ic
use
baselin
lower
chronic
asthma
sever
score
compar
rvneg
patient
patient
rv
infect
also
less
like
histori
hospit
asthma
exacerb
patient
rv
infect
significantli
less
like
ic
user
potenti
benefici
effect
icss
viral
exacerb
asthma
recent
report
studi
septemb
epidem
asthma
children
johnston
et
al
found
children
requir
emerg
room
treatment
asthma
less
like
icss
prescrib
children
asthma
commun
requir
emerg
care
icss
potent
antiinflammatori
agent
demonstr
amelior
abnorm
bronchial
epithelium
patient
asthma
nasal
mucosa
allerg
rhiniti
injuri
airway
epithelium
differenti
phenotyp
asthma
epithelium
like
import
risk
factor
rvassoci
asthma
demonstr
differenti
infect
rv
normal
disrupt
asthmat
airway
epithelium
addit
studi
shown
ic
use
dramat
reduc
rate
hospit
asthma
children
mani
known
associ
viral
infect
patient
rv
infect
also
significantli
like
smoker
increas
risk
rv
infect
smoker
asthma
biolog
plausibl
role
tobacco
smoke
risk
factor
varieti
respiratori
infect
investig
cigarett
smoke
previous
identifi
risk
factor
communityacquir
pneumonia
addit
risk
factor
acquisit
certain
respiratori
infect
cigarett
smoke
also
identifi
risk
factor
lower
respiratori
tract
complic
rv
infect
cohort
older
adult
year
age
experiment
evid
date
also
suggest
airway
epithelium
site
damag
smoke
investig
effect
cigarett
smoke
airway
epithelium
reveal
chronic
smoker
increas
airspac
epitheli
permeabl
could
contribut
host
suscept
infect
experiment
model
rv
also
easili
infect
undifferenti
cell
addit
neutrophil
predomin
inflammatori
cell
associ
respiratori
virus
tobacco
use
smoke
may
well
host
factor
predispos
rvassoci
asthma
exacerb
prime
lower
airway
neutrophil
immunopatholog
effect
find
mani
patient
asthma
present
emerg
depart
acut
asthma
smoke
tobacco
adult
asthma
exacerb
associ
viral
infect
serv
illustr
import
understand
relationship
tobacco
smoke
respiratori
viral
infect
patient
asthma
exacerb
smoke
nonus
icss
characterist
adult
hospit
rvassoci
asthma
exacerb
adjust
ci
vs
rvneg
patient
ic
use
modifi
risk
rv
infect
p
p
even
adjust
asthma
sever
interact
smoke
ic
use
deserv
explor
sinc
icss
may
affect
rvinduc
ill
restitut
airway
epithelium
well
modif
host
respons
viru
may
differ
smoker
nonsmok
tobacco
cessat
may
even
import
role
modifi
outcom
rv
infect
among
person
asthma
sever
potenti
limit
studi
consid
first
studi
rel
small
conduct
singl
univers
medic
center
find
may
generaliz
popul
studi
detect
higher
rv
infect
preval
acut
adult
asthma
exacerb
howev
one
studi
use
nasal
specimen
yield
rv
preval
similar
studi
suggest
rel
higher
rate
viral
detect
investig
may
explain
potenti
differ
detect
rate
nasal
sputum
specimen
howev
use
methodolog
compar
patient
time
point
conclus
drawn
valid
addit
abl
obtain
convalesc
specimen
studi
patient
includ
rv
posit
hospit
admiss
although
signific
differ
gener
demograph
characterist
studi
patient
followup
would
suggest
rv
infect
rate
may
differenti
studi
patient
return
followup
like
smoke
smoke
appear
characterist
rv
infect
convalescentphas
rv
infect
preval
could
underestim
preval
rv
infect
convalesc
followup
visit
lower
previous
report
asymptomat
popul
singl
individu
studi
detect
followup
symptom
respiratori
infect
significantli
exacerb
asthma
previou
report
rv
detect
asymptomat
individu
vari
subject
asthma
subject
without
asthma
studi
vari
length
time
subject
upper
respiratori
tract
symptom
preced
sampl
collect
three
studi
howev
perform
children
asthma
recent
studi
jartti
et
al
reveal
onset
symptomat
respiratori
infect
rv
rna
may
take
week
disappear
nasopharynx
children
admit
acut
respiratori
wheez
lastli
etiolog
exacerb
rvneg
group
determin
larg
proport
almost
certainli
caus
respiratori
virus
evidenc
high
preval
upper
respiratori
tract
symptom
summari
data
confirm
rv
respiratori
infect
etiolog
factor
sever
asthma
exacerb
necessit
hospit
patient
rv
infect
appear
uniqu
characterist
includ
current
smoke
nonus
icss
role
smoke
icss
host
suscept
viral
infect
asthma
deserv
explor
sinc
signific
implic
indic
ic
use
decreas
sever
asthma
exacerb
diseas
morbid
find
hospit
sever
asthma
associ
rv
posit
consid
signific
view
lack
licens
antivir
rv
unlikelihood
multipl
serotyp
vaccin
develop
import
rv
infect
set
illustr
need
research
